Future studies will be aimed at determining the exact contributions of both leptin-receptor signaling and additional metabolic, endocrine, and proinflammatory pathways induced by hyperglycemia in normal and malignant breast epithelial cells. This evidence concerns the gene LEPR and Hyperglycemia.